ECM Weekly (1 Dec 2019) - Venus Medtech, Alphamab, CMC REIT, XD, BAM
Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming IPOs. It has...
616 Views
Alphamab (康宁杰瑞) IPO: You Will Likely Be Zeroed
Alphamab launched book building to raise up to USD 234 million to list in Hong Kong. In our previous notes, we covered the company’s key pipeline...
700 Views
Alphamab Oncology IPO Initiation: Clear Diagnosis
Alphamab Co Ltd (1728643D CH) is a pre-revenue biotech company with a focus on research and development, manufacturing and commercialisation of...
582 Views
Alphamab (康宁杰瑞) Pre-IPO: Promising Readings from PHIP Updates
Alphamab obtained approval from HKSE last week and started pre-marketing for its USD 200-300m deal this week. In our previous notes, we covered the...
539 Views
Alphamab (康宁杰瑞) IPO: Thoughts on Base-Line Valuation
Alphamab, a China-based biotech company, is seeking to raise USD 200 to 300 million via a listing on the Hong Kong Stock Exchange. In our previous...
626 Views